Unfazed by Brexit blues, UK biotech trade group celebrates boisterous year of venture dollars with record £1.1B total
A record year of venture investing has floated UK’s biotech boat, with the money flow in 2018 gushing over the £1 billion mark for the first time.
A total of £1.1 billion was raised thanks to a boom in late-stage financings, according to the latest report from the UK BioIndustry Association and Pharma Intelligence. While seed funding stayed flat at £27 million and A rounds nabbed a collective £213 million, it was Series B and post-B financings that delivered the most impressive numbers at £393 million and £480 million, respectively.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.